ZEVRA THERAPEUTICS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Zevra Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q2 2024.
  • Zevra Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $70K.
  • Zevra Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $177K, a 65.2% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Zevra Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$33K, a 197% decline from 2021.
  • Zevra Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $34K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $177K $70K +$144K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $33K -$70K +$33K +32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0 $0 -$719K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $719K $177K +$210K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $509K -$74K +$641K +89.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$132K -$103K -$99K -2475% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$33K $719K +$685K +2015% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$718K -$33K -$33K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$685K -$715K -$715K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $30K -$4K -$4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $34K $34K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $0 +$34K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$34K -$37K -1233% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 +$9K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q4 2019 -$22K -$8K +$11K +57.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$33K $3K +$63K Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$96K -$9K +$30K +76.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$126K -$8K $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$126K -$19K +$12K +38.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$138K -$60K -$56K -1400% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$82K -$39K -$35K -875% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$47K -$8K -$4K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$43K -$31K -$27K -675% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-30
Q3 2017 -$16K -$4K +$15K +78.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$31K -$4K $0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$31K -$4K -$16K -133% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$15K -$4K -$3K -300% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$12K -$19K -$39K -195% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-30
Q2 2016 $27K -$4K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-30
Q1 2016 $12K +$5K +71.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-30
Q4 2015 -$1K -$28K -104% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 $20K +$58K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q1 2015 -$10K $7K +$12K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$22K $27K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 -$38K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-16
Q2 2014 -$6K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-16
Q1 2014 -$5K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.